{"id":"W3205072810","doi":"10.1182/bloodadvances.2021004970","title":"Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Brentuximab vedotin; Internal medicine; Quality of life (healthcare); Oncology; Confidence interval; Classical Hodgkin lymphoma; Hazard ratio; Lymphoma; Hodgkin lymphoma; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003156052,0.0004728862,0.001435656,0.000269455,0.0001740197,0.0007311503,0.0005296912,0.0005690611,0.003196162],"category_scores_gemma":[0.002997016,0.0002596638,0.002261401,0.0004274505,0.0003752538,0.0005728466,0.0004268308,0.001915652,0.0002765787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058992,"about_ca_system_score_gemma":0.0008161484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001289412,"about_ca_topic_score_gemma":0.002925124,"domain_scores_codex":[0.998755,0.000710854,0.00009094702,0.0001186115,0.0001906521,0.0001339976],"domain_scores_gemma":[0.9987832,0.0004447762,0.0003655562,0.00008027299,0.00007973547,0.0002465339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9097415,0.005295595,0.01394884,0.001198253,0.009231793,0.00007160076,0.00009435738,0.00258702,0.008972875,0.0002229618,0.001723667,0.04691158],"study_design_scores_gemma":[0.4184774,0.3854411,0.1676227,0.0002457976,0.01329785,0.0002583458,0.0001661753,0.00628266,0.00353371,0.0005345741,0.004074563,0.00006521408],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921297,0.003816154,0.000331079,0.0002468634,0.00007849619,0.000505531,0.001608434,0.00002323545,0.001260377],"genre_scores_gemma":[0.9968448,0.0006606823,0.0003201694,0.0001815044,0.00004154226,0.0004730324,0.001095464,0.000005391265,0.0003774161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003196162,"threshold_uncertainty_score":0.01669097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02921630299650604,"score_gpt":0.3286447617787381,"score_spread":0.299428458782232,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}